Business Focus
Clinical Focus
Spotlight
Academy
CME/CE
Job Board
Subscribe
- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
State Roundup: Minnesota launches addictive drugs database
In January, Minnesota pharmacies were required to report data on addictive drugs to the Minnesota Prescription Monitoring Program.
In January, MINNESOTA pharmacies were required to report data on addictive drugs to the Minnesota Prescription Monitoring Program. By late March, doctors, dentists and pharmacists will be able to tap into the system to identify patients who get too many habit-forming medicines. Minnesota joins 33 other states that monitor prescriptions for controlled substances such as amphetamines, barbituates, and some diet pills. The state database, funded by a $400,000 federal grant, is expected to track more than a million prescriptions a year.
Related Videos
Related Content
